bioLytical Laboratories Inc. announced today that it has launched its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test for professional use in
أعلنت شركة bioLytical Laboratories Inc. اليوم أنها أطلقت اختبار الأجسام المضادة INSTI® Multiplex HIV-1/2 Syphilis وأنه أصبح متاحًا للاستخدام من
LeddarTech’s award-winning LeddarVision solution QUEBEC CITY, March 27, 2023 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most
CIDADE DO QUEBEC, March 27, 2023 (GLOBE NEWSWIRE) — A LeddarTech®, líder mundial no fornecimento da mais flexível, robusta e
La solution LeddarVision de LeddarTech plusieurs fois primée QUÉBEC, 27 mars 2023 (GLOBE NEWSWIRE) — LeddarTech®, chef de file de
NEW YORK, March 26, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
NEW YORK, March 26, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
NEW YORK, March 26, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers